Received for publication 19 June 1980 copper.5 However, this relationship has not previously been systematically studied and reported in children. Hepatic copper concentration is physiologically raised in fetuses and newborn infants6 and remains raised until 6 to 12 months of age.7
Hence, liver sections from a neonatal group have been examined for CAP and histochemical copper in the present study.
In Wilson's disease, copper accumulation in the liver (usually >4 ,umol/g of dry liver) and other organs is associated with tissue damage.8 The relationship between the measured hepatic copper concentration and grades of staining for CAP, and histochemical copper was assessed in patients with Wilson's disease and the findings compared with other groups.
Methods

STUDY GROUPS
Sixty-five liver sections were assessed from (1) neonatal group (six) (2) childhood group (38), and (3) Wilson's disease (21) . 970
Neonatal group All six patients died from non-hepatic causes and included one fetus of 27 weeks' gestation, the result of an antepartum haemorrhage, and one pre-term infant of 35 weeks' gestation with congenital heart disease (CHD) who died on the third post-partum day from heart failure. The four term infants included one child with Down's syndrome who died on the first day post-partum from a tear in the falx cerebri, one infant with a tracheo-oesophageal fistula who died from respiratory failure at 3 weeks of age, and two infants with CHD who died from heart failure at 7 days and 2 months respectively. Wedge samples were obtained at necropsy in all cases.
Childhoodgroup
The 38 children were at least 18 months old, and each group was age-matched. No child had received copper chelation therapy.
Eight children were ultimately proved to have no evidence of liver disease. Percutaneous liver biopsies were obtained in six and wedge samples were obtained at necropsy in two.
Fourteen children suffered with intrahepatic cholestasis of childhood (IHCC 1, 5; 6, 10; 8, 17; 13, 21 tration (Fig. 2) . Grade 1 rhodanine staining was present in sections from this patient and two others with normal hepatic copper levels (Fig. 3) Usually, slight rises of hepatic copper concentration (<4 ,umol/g) were associated with grade 1 staining and large increases of hepatic copper levels (>4 ,umol/g) were associated with grade 2 or grade 3 staining. A wide range of hepatic copper concentrations occurred with grade 2 or grade 3 staining, thus limiting useful interpretation of grades of histological staining in individual patients.
All patients in the neonatal group were less than 3 months of age. The hepatic copper concentrations were physiologically increased6 and liver sections appeared normal. The study of this group revealed typical granules of CAP in all cases, suggesting that it is also physiological and represents a normal hepatocyte protein rather than an abnormal tissue copper protein (metallothionein) as previously suggested.4 CAP has been described in primary biliary cirrhosis and chronic liver disease.1 Histologically, all liver sections in the neonatal group were normal, so demonstrating that CAP is not an artefact of chronic biliary obstruction or liver disease.
CAP was seen in one fetus of 27 weeks' gestation demonstrating that it develops in utero, possibly at an early age stage, but more studies will be required to confirm this observation. The biochemical composition of CAP, which is located in lysosomes,18 is not established. It is unlikely to be caeruloplasmin, which has been localised to the endoplasmic reticulum,19 but may be similar to a copper-rich form of metallothionein isolated from lysosomes of normal newborn bovine liver.20
The study of copper and CAP in the neonatal and childhood groups revealed additional evidence of an association. The 
